Few data are available on adolescent users because most behavioral studies on anabolic-androgenic steroids (AAS) abuse have been performed in adults. Studies evaluating the impact of long-term effects of AAS abuse on the prepubertal phase are even more uncommon. Accordingly, this study was developed to test the hypothesis that changes induced by the use of AAS during the adolescent phase may be noted in the adult phase even when the AAS treatment cycle is discontinued. Therefore, not only behavioral changes but also possible autonomic and electrolyte disorders were evaluated. For this purpose, we used male prepubertal, 26-day-old (P26) Wistar rats that were treated with vehicle (control, n = 10) or testosterone propionate (TP; 5 mg/kg intramuscular (IM) injection, AAS, n = 10) five times per week for 5 weeks, totaling 25 applications during the treatment. Aggression tests were performed at the end of the cycle (P54-56), whereas open-field tests (OFTs), elevated plus maze (EPM) behavioral tests and measurements of heart rate variability (HRV), fluid intake and pathology were conducted in the adult phase (P87-92). The AAS group showed greater aggressiveness in the pubertal phase and higher levels of horizontal and vertical exploration and anxiety-related behavior in the adult phase than the control group (P b 0.05). HRV tests showed an increase in sympathetic autonomic modulation, and hydroelectrolytic assessment showed lower basal intake levels of hypertonic saline than the control group (P b 0.05), without statistically significant changes in the basal intake of water. These data together suggest that the use of AAS during the prepubertal phase induces behavioral, autonomic and hydroelectrolytic changes that manifest in the adult phase even when treatment is discontinued in late adolescence in rats.
Experimental studies also corroborate the highly aggressive behavior induced by AAS injected during adolescence. For example, Farrell and McGinnis [8] showed that male rats exposed to AAS during puberty were more aggressive towards male rats (resident or intrusive opponent) during aggressive encounters [9] . Cardiovascular dysfunction, including sudden cardiac death, is one of the main side effects associated with AAS abuse, both in AAS users and animal models of AAS abuse, concomitant with the behavioral changes observed [10] [11] [12] [13] .
Although several studies have shown direct cardiac changes induced by AAS, including ventricular hypertrophy associated with diastolic dysfunction [14, 15] , thrombosis and myocardial infarction [16, 17] , indirect effects of AAS on heart morphology and function are difficult to exclude. Thus, the cause and effect relationship between the heart and other tissues remains unclear in the literature. For example, an increase in peripheral resistance/blood pressure has long been observed in studies of experimental models of AAS abuse [18, 19] .
Cardiac arrhythmias and sudden death are also associated with AAS abuse [20, 21] , and some authors argue that cardiac electrophysiological changes may not only be attributed to myofibrillar disorders, tissue necrosis and fibrosis, among other factors, but other indirect mechanisms may also exist that cause these effects on heart excitability [22] . Therefore, identifying the extra-cardiac sites affected by AAS abuse may bring new perspectives and help establish the main mechanisms underlying cardiac abnormalities induced by AAS.
Pereira-Junior et al. [22] first reported cardiac autonomic dysfunction as a potential mechanism underlying cardiac dysfunction and sudden death associated with AAS abuse in adult rats [22] . This is unsurprising when considering that sympathetic hyperactivity is a mechanism known to generate cardiac arrhythmias, given the decreased ventricular fibrillation threshold [23] .
Therefore, adverse effects on the electrophysiological responses to sympathetic hyperactivity may contribute to the development of a proarrhythmic substrate [24] . An excess of androgens has already been related to increased sympathetic tone [25] . Together, these data led us to recognize that AAS abuse may trigger chain events that eventually cause sudden death induced by sympathetic hyperactivity.
It has not been studied thus far whether the possible AAS-induced autonomic imbalance persists throughout the adult life period of rats treated with AAS during the adolescent phase. In this study we evaluated the effects of testosterone not only on heart rate variability but also on fluid intake and the behavior of adult rats treated with testosterone during the adolescent life period.
Our hypothesis is that AAS abuse during this critical period of time may alter not only animal behavior in the adolescent phase but also affect the behavior, heart function and hydroelectrolytic balance in the adult phase of rats because adolescence is a critical period of brain development, partly due to increased hormone levels [26] .
Material and methods
The present study was conducted according to the "Guide for the Care and Use of Laboratory Animals" (NIH Publication No. 85-23, revised in 1996) , and the experimental protocols were approved by the Ethics Committee on Animal Use of the Federal Rural University of Rio de Janeiro in accordance with Brazilian law (Law No. 11.794 of October 8, 2008 ).
Animals
Forty intact male Wistar rats, with initial body weights between 110 and 130 g, were used in the present study. All animals were housed in cages (four to five animals/cage) under controlled temperature (22 ± 2°C), with daily exposure to a 12-hour light-dark cycle (lights off at 7:00 pm) and free access to water and standard chow.
In addition, older and heavier male animals, initially with body weights of approximately 450 g (n = 10), remained housed throughout the experiment with ovariectomized females weighing approximately 250 g (n = 10), except during the aggression test, at which time the females were removed from the box immediately before the interaction between males intended to stimulate their partner's territorial aggressiveness (see below). Males in the company of ovariectomized females were housed in plastic boxes (35 × 50 × 35 cm) . To stimulate territorial aggressiveness, these males received training (five times per week) with other sparring animals (lighter and younger; approximately 200 g and 50 days old) for 10 min daily, with weekly rotations of their respective opponents, for four consecutive weeks.
Experimental design
Prepubertal (postnatal day 26, P26) male rats were randomly distributed into two groups: the TP group (AAS, n = 20) received testosterone propionate (TP; Perinon®, Perini-Brasil Laboratory, 5 mg kg −1 body weight), and the control group (Control, n = 20) received an equal volume of vehicle (corn oil); both were given intramuscularly (always between 10:00 and 11:00 am) as five injections per week for 5 weeks as previously described [27] . The dose of AAS used in the present study is equivalent to the dose used in humans to reach a high muscle weight gain during AAS abuse. The treatments were discontinued after 5 weeks of AAS or vehicle injections to assess the longterm effects of AAS administered during the prepubertal/pubertal phase of rats. The aggression tests were conducted in the final week of treatments (P54-56) in 20 animals (n = 10/group), whereas the behavioral, heart rate variability (HRV) and fluid intake tests (all described next) were performed in other 20 rats (n = 10/group) during their adult life (P84-90),~3-4 weeks after the final day of treatment in both groups. The reason for using different subsets of animals in aggression test and behavioral, autonomic and hydroelectrolytic studies is because aggressive stimulus could influence the other parameters and lead to misleading results. Postmortem study (pathology) was performed at the end of the protocol (P92) as shown in Fig. 1. 
Behavioral studies

Aggression tests
The aggression test consisted of placing the intruder and resident rats alone for 10 min in a clean polypropylene box with a closed, high and transparent acrylic lid, without the availability of food and water. The aggressiveness of the intrusive rat was observed during the test using a scoring system, wherein a score was tallied each time the rat performed one of the following tasks: 1. Attack threat, 2. Attacks by bites, 3. Attacks by sideways kicks, 4. Attacks by boxing, 5. Pelvic pressure or 6. Position of dominance. The tests were performed at the beginning of the last week of the TP cycle and were recorded for further individual analysis off-line [27] .
Open-field test (OFT)
We used a quadrangular open field (100 × 100 × 30 cm) split into 25 equal quadrants to assess the exploratory activity of animals as previously reported by our group [28] . Briefly, the experimental assay started at 7 pm and was conducted in a dark room with a red light. Each animal was individually placed in the center of the open field at the beginning of the test, and the following parameters were recorded: 1. Locomotor activity (the number of times the animal invaded with all four legs in one of the arena fields): counted as the total number of squares crossed; 2. Rearing (animal standing on his hind legs with the torso perpendicular to the floor and his head pointing upwards, touching or not touching the walls of the open field with the forefeet); 3. Time of inactivity: recorded as total time without movement; and 4. Grooming episodes (number of movements performed with one or both front or hind legs towards the mouth or head, which may be continued towards the pinnae, and/or licking movements primarily directed towards the lateral portions of the body and genital area), which was counted as 4.1 Total number of grooming activities and 4.2 Grooming time (time spent performing grooming activities), counted as total time spent performing grooming.
The area was cleaned with a 5% ethanol solution between each test. The locomotor activity was recorded during the testing period, and the elements of exploratory activity were scored by observation and counted off-line.
Elevated plus maze (EPM) test
The elevated plus maze (EPM) test validated by Pellow et al. [29] was performed to evaluate animal anxiety. Briefly, the apparatus used consisted of two opposing open arms (50 × 10 × 40 cm) and two closed arms (50 × 10 × 1 cm), also opposing, in the form of a Greek cross, connected by a central platform (10 × 10 cm) 50 cm above the floor level [29, 30] . The test was conducted under a dim red light (5 lx).
The animals were placed in the center of the apparatus with the head turned to one of the closed arms, and their behavior was observed for 5 min. The following parameters were assessed: 
HRV and spectral analysis study
Electrocardiograms (ECGs) were performed in animals from both experimental groups. Twenty-four hours before the assessment, the animals were immobilized and shaved across the chest length, and a foam electrode (3 M do Brasil LTDA, Sumaré-SP, Brazil) approximately 1.5 cm in diameter was attached to each hemithorax. The rats were connected to the ECG acquisition system (Amplifier MP100A CE, BIOPAC SYSTEMS INC) moments before the recording of the ECG. The signals were acquired at a sampling a frequency of 10 kHz and 12-bit amplitude resolution, and the software AcqKnowledge® (version 3.8.1) was used to acquired and view the recordings.
All animals were rigorously evaluated during the same period of the day (~7-9 h am) and in similar positions to collect the ECG data with minimal interference from the circadian cycle.
The ECG recordings lasted 600 s, and the entire signal processing of HRV was performed using Matlab-based algorithms [22] from the Cardioseries software (Version1.1). Tachograms representing 600 s were generated after the detection of the R wave peak by counting all cardiac fluctuations within this time period [22] . The parameters assessed in the time domain were the following: 1. Heart rate, 2. Standard deviation of RR intervals and 3. Root mean square of successive differences of RR intervals [22, 32] . The tachograms were resampled to equal intervals using the cubic interpolation method, at 10 Hz, and the linear trend was removed for the spectral analysis of HRV (frequency domain) [22, 32] . The power spectrum was obtained with a rapid decay based on the Fourier method (Welch's periodogram: 256 points, 50% overlap and Hamming window). Spectral amplitudes were measured in two frequency bands: low frequency (LF: 0.2-0.8 Hz) and high frequency (HF: 0.8-2.5 Hz); the power (ms 2 ) was estimated as the area under the spectrum within those frequency bands [22, 32] .
2.5. Hydroelectrolytic regulation 2.5.1. Measurement of water and sodium intake Intact animals were acclimatized for 5 days in individual metabolic cages with food and two polypropylene volumetric water bottle drinkers (graduated in 0.1 ml), one containing water and the other containing NaCl solution (1.8%), available ad libitum. Hypertonic saline is normally unsavory for rats and humans. The ingestion of saline by rats only occurs when there is a deficit in the Na + concentration and volume of body fluids. The fluid intake is expressed in ml/100 g bw for varying periods, in minutes, according to the experimental protocol (60, 120, 180, 240 and 300 min).
Protocol of water and sodium depletion
Sodium depletion was performed by the administration of furosemide (subcutaneous (SC) administration) at a dose of 20 mg/kg once the acclimatization period was completed. The animals were returned to their cages after being washed immediately after the treatment to remove traces of sodium. A low-sodium diet (corn meal) was provided to the animals for 24 h before the experiment (intake response evaluation). The corn meal was removed after that period, and two glass water bottle drinkers (graduated in 0.1 ml) with stainless steel nozzles containing the same liquids from the acclimatization period were mounted on the front of the metabolic cages. Furosemide is widely used as a classic model of hyponatremia and hypovolemia induction in rats, given its potent natriuretic/diuretic effect that induces sodium appetite [33] [34] [35] [36] [37] .
Body weight assessment and pathology
Body weight was measured just before the beginning of the experiments (basal body weight: at P26), and at P60 and P92 in both groups. At the end of study (P92) animals were weighed and euthanized by decapitation. Thereafter, testicles, heart, lungs, liver, kidneys and adrenals were dissected, pruned from fat, weighed and the relative organ weight calculated as: organ weight (mg)/body weight (g).
Statistical analysis
The results were expressed as mean ± SEM. Data were analyzed by one-way or two-way analysis of variance (ANOVA) for repeated measurements using the Graphpad Prism software (version 6, Graphpad Software, Inc., San Diego, USA). It was performed a Shapiro-Wilk test to evaluate the normality data distribution, and all variables had a normal distribution. To detect significant differences among the experimental groups and weeks, ANOVAs were supported by the Bonferroni post-hoc tests, only when overall effects were significant (always the case). In the pathology, data were analyzed using paired sample t-test. Values P b 0.05 or P b 0.01 were considered statistically significant and always represented post-hoc analysis after an overall effect was detected by ANOVA. Table 1 shows basal body weight (at P26) and its values in the fourth (P60) and ninth (P92) weeks after the study began. There was no statistically significant difference in body weight between the groups over time. The AAS group showed a significant decrease in the relative weight of testicles (P b 0.01) when compared with the control group at the end of the experiment (P92), suggesting that anabolic steroids were effective at blocking the hypothalamic-pituitary-gonadal axis even when treatment was discontinued at early adulthood. Treatment with TP did not affect the other pathological parameters observed, including the relative weight of the heart, lungs, liver, kidneys and adrenal glands (Table 1) . Fig. 2 shows the results of aggression tests from all animals. As shown, there was a statistically significant increase in both the number of attacks (6.80 ± 1.20 vs. 2.88 ± 1.10 number of attacks, P b 0.05) and threats (7.40 ± 2.16 vs. 2.22 ± 1.23 number of attack threats, P b 0.05) in AAS vs. control animals, respectively.
Results
Body weight and pathology
Behavioral tests 3.2.1. Aggression test
There was no statistically significant difference between groups (P N 0.05) for the other test parameters (pelvic pressure and submission). These data suggest an increase in aggressiveness induced by the testosterone treatment one month after beginning the treatment (P54-56), which was at the end of the cycle of testosterone injections.
OFT
The locomotor activity was assessed using the number of squares crossed and the number of rearing activities (vertical exploration) by the animals. Fig. 3 shows the statistically significant increase in the number of quadrants crossed (185.6 ± 12.5 vs. 166.0 ± 10.6, P b 0.05) and in the number of rearing activities (48.5 ± 1.5 vs. 42.2 ± 2.6, P b 0.05) during the 5 min the rats were exposed to the OFT in the AAS vs. control groups, respectively.
The time of inactivity may also be related to exploratory activity. Fig. 3 shows that the AAS group showed a significant decrease in this parameter compared with the control group during the 5 min the rats were exposed to the OFT (AAS: 19.4 ± 1.9 vs. control: 30.8 ± 2.6 s, P b 0.01). This result also corroborates the number of quadrants crossed and the rearing results previously shown; AAS treatment increased motor and exploratory activity while decreasing the time of immobility.
The amount of fecal bolus may be related to animal anxiety. Fig. 3 shows that the production of fecal bolus increased in the AAS group during the 5 min they were exposed to the OFT (control: 3.6 ± 0.9 vs. AAS: 4.9 ± 0.6, P b 0.05).
The amount of fecal output, which may be related to anxiety, was increased in adult animals even though the testosterone treatment was only performed during the adolescent phase, as found in the locomotor/exploratory activity evaluation tests.
EPM test
The number of closed-arm entries in the EPM may also be used as a measure of the animals' exploratory activity. Fig. 4 shows that the animals from the AAS group showed an increase in the number of closed-arm entries during 5 min compared with the control group (control: 13.7 ± 1.2 vs. AAS: 28.3 ± 1.2 entries/5 min, P b 0.01), although no difference was found in the time spent in the closed arms compared with the control group (control: 233.6 ± 19.2 vs. AAS: 245.5 ± 20.4 s, P N 0.05). Conversely, the time spent by animals in the open arms, often used as a parameter to evaluate anxiety, decreased in the AAS group compared with the control group (control: 38.6 ± 3.1 vs. AAS: 32.0 ± 2.1 s, P b 0.05). The other parameters evaluated in the maze were not significantly different between groups (P N 0.05, data not shown). Data are mean ± S.E.M. n = 10/group. ⁎⁎ P b 0.01 vs. control. 
HRV and spectral analysis study
Although the animals' heart rate was not different between groups (Fig. 5A) , there was a statistically significant decrease in HRV assessed in the time domain parameters studied in the AAS group compared with the control: 1. standard deviation of all normal RR intervals (SDNN: 86.97 ± 6.15 for the AAS vs. 159.0 ± 8.10 ms for control, P b 0.01) and 2. root mean square of successive differences between adjacent normal RR intervals (RMSSD: 141.1 ± 14.6 for the AAS vs. 227.9 ± 15.34 ms for control, P b 0.01).
Regarding the HRV study in the frequency domain, Fig. 6 shows that a statistically significant decrease in high-frequency wave power was found in the AAS group compared with the control (HF, AAS: 20.0 ± 3.27 vs. control: 53.75 ± 3.24 ms 2 , P b 0.01, Fig. 6B ), although no statistically significant difference in low-frequency wave power was found between the groups (LF, AAS: 45.81 ± 1.31 vs. control: 44.69 ± 1.61 ms 2 , P N 0.05, Fig. 6A ). Consequently, together these parameters significantly increased the LF/HF ratio in the AAS group vs. control: 2.82 ± 0.51 vs. 0.86 ± 0.07, respectively (P b 0.01, Fig. 6C ). These data suggest that testosterone administered during adolescence altered the sympathetic-vagal balance toward increased sympathetic modulation in the adult phase of rats.
Fluid intake study
The hydroelectrolytic homeostasis assessment was performed using two experimental procedures. Initially, the animals were evaluated at baseline conditions as shown in Fig. 7 . No significant differences were found in water intake in the control and AAS groups in the time periods evaluated (Fig. 7B, P N 0.05) . Conversely, there was a statistically significant decrease in the intake of hypertonic saline in the AAS group compared with the control. This difference appeared at 180 min (Fig. 7A , AAS: 0.21 ± 0.03 vs. control: 0.50 ± 0.08 ml/100 g, P b 0.001) and lasted until 300 min (AAS: 0.21 ± 0.03 vs. control: 0.56 ± 0.08 ml/100 g, P b 0.001). Conversely, the testosterone treatment induced a reduction in the specific appetite for sodium by the 60-minute time period (Fig. 7C , AAS: 0.048 ± 0.019 vs. control: 0.34 ± 0.08, P b 0.01), and this reduction was maintained until the last time period assessed (P b 0.01).
In spite of fluid intake in the groups submitted to volume depletion, no statistically significant differences (P N 0.05) were found in either dipsogenic or natriorexigenic response in the time periods evaluated (data not shown).
We suggest that prolonged treatment with testosterone appears to be critical in the tonic inhibition of sodium appetite at baseline conditions. Treatment with testosterone does not appear to modulate induced intake because such effect was not observed in homeostatic challenge conditions.
Discussion
The main finding of this study is the realization that behavioral, autonomic and hydroelectrolytic alterations induced by TP are present in adult rats, even when the administration of the anabolic steroid is initiated in the prepubertal phase and discontinued at the onset of the adult phase.
The intramuscular administration of TP in supraphysiological doses for a five-week period resulted in no statistically significant difference in body weight between the treated group and the control group, in contrast to the study by Cunningham and McGinnis [27] , who noted a drop in body weight in animals treated with AAS from the fourth week, thus remaining the following week, compared with the control treated with vehicle. This difference between our study and that of Cunningham and McGinnis [27] may have resulted from differences in the AAS administration protocol and the period of time in which body weight was assessed. While we started the AAS treatment at P26 and measured body weight only at P26, P60 and P92, Cunningham and McGinnis [27] started at P40 and assessed body weight from P68 to P89.
The groups that received TP showed lower relative weights of testicles (P b 0.05) when the values were corrected for their respective body weights. This data suggests that testicular atrophy most likely resulted from the inhibition of the hypothalamic-pituitary-gonadal axis through anabolic steroid activity. Noorafshan et al. [38] found the same level of reduction in testicular weight of animals, albeit in doses and time periods greater than our protocol of AAS administration. They also suggested that the explanation for this result may be, at least partly, the establishment of a negative feedback loop in the hypothalamus and pituitary gland of rats submitted to this treatment. It is worth noting that the administrations of AAS in the present study were started and discontinued before the adult phase, and surprisingly, testicular atrophy was observed in the adult phase of rats treated with AAS, suggesting an irreversible effect on the hypothalamic-pituitary gland axis from the protocol of administrations used.
From the behavioral standpoint, users of high doses of AAS show a high incidence and prevalence of psychiatric symptoms. The differences in symptoms between users may be related to the dosage used. Thus, more intense psychotic symptoms are associated with users who consume more than 1000 mg of testosterone per week. However, the symptoms usually disappear after discontinuation of AAS use, although they may persist for up to a month even with adequate anti-psychosis medication [39] .
The results from the aggression test performed at the end of the cycle of AAS injections indicated that the group treated with TP showed a significantly higher score than the control group for occasions of attack (threats or effective). There was no statistically significant difference in the other test parameters (pelvic pressure and submission) between groups (P N 0.05). These results corroborate the study by Breuer et al. [40] , who showed that TP administration in Long-Evans rats for 12 weeks (dose of 5 mg/kg/day five times weekly) significantly increased the aggressiveness of those animals compared with the control group. A study by Lumia et al. [41] showed that treatment with testosterone (1 mg/kg, 3 times weekly) for 10 weeks in Long-Evans rats increased dominant posture and reduced submissive posture compared with control rats. Conversely, Breuer et al. [40] administered TP, nandrolone decanoate (ND) and stanozolol in Long-Evans rats (5 mg/kg, five times a week for 12 continuous weeks), and aggressive behavior only increased significantly in the group treated with TP compared with its control. The group treated with ND and its control group showed similar levels of aggressiveness, and surprisingly, the group treated with stanozolol showed significantly lower levels of aggressiveness than the other treated groups compared with their controls. This paradoxical effect of stanozolol in abolishing aggressive behavior was attributed to the different mechanisms of action of cellular and molecular targets of AAS in the central nervous system (CNS). The study by McGinnis et al. [42] showed that treatment with TP increased the rodents' aggressiveness associated with physical provocation of animals (through tail pinch). The authors of this study speculated that TP sensitizes the animals to strike attacks on the intrusive animal and stimulates their aggressiveness.
In contrast, the study by Long et al. [43] showed that SpragueDawley rats receiving ND (2 mg/kg/day or 20 mg/kg/week for 4 weeks) showed higher levels of aggressiveness compared with the control group. Male rats treated with ND showed dominance in the access to the water bottle drinker compared with the control group when using the competition test for water intake as a measure of aggressiveness [44] . The study by McGinnis [45] showed that physical provocation stimulates aggressiveness in rats treated with testosterone, ND and stanozolol and is significantly different from the control group. However, animals treated with AAS showed no aggressive behavior in the absence of physical provocation in any of the groups compared with the control [42] . Most studies assessing the effects of testosterone show that it causes changes in social interaction, specifically sexual and aggressive behaviors [45] [46] [47] . However, these effects are contradictory in nature because they depend on the type of androgen, dose administered, length of treatment and animal line, age and sex [48] .
In humans, the indiscriminate use of AAS is associated with behaviors including aggressiveness and violence without provocation. Chronic use intensifies aggressiveness, mainly through verbal aggression, provocation to fight and brawl and increased violence against women. This type of use also contributes to elevated levels of homicides committed by teenagers. Adolescent users are more susceptible to acts of violence, impatience, impulsiveness and irritability, and such effects are positively correlated with serum levels of testosterone [45, 49] . Controversially, some studies showed no evidence of AAS increasing aggressiveness in healthy subjects when administered at high doses [50, 51] . In our study, we began treatment with AAS of rats prepubertally and noted an increase in aggressive behavior by the fifth week of treatment, that is, with animals near the young-adult phase. The use of the type of protocol used herein may explain differences from the results found by other studies that observed no increase in aggressive behavior of rats treated with AAS because their treatments began in the adult phase of rats, as in the studies by McGinnis et al. [42] and Kindlundh et al. [52] .
We noted that an increase occurred in the OFT both in horizontal exploration (number of squares crossed) and vertical exploration (number of rearings), and there was a decrease in the time of inactivity in animals treated with TP compared with the control. According to Rygula et al. [53] , changes in exploratory activity could be related to changes in motivational state. It is noteworthy that the motivational deficit may be a presenting symptom in patients with depression. In this context, these data may be related to the observation of the Buddenberg et al. [54] , who showed that testosterone administration attenuated immobility in the forced swim test in rats in a dosedependent manner, indicating an antidepressant effect of the AAS in this model.
Conversely, these results differ from many other studies, which suggest that AAS treatment does not change spontaneous locomotor activity [55] [56] [57] [58] [59] [60] [61] [62] [63] . Differences in the type of AAS, protocol, age of animals (that is, the period during which the treatment is started) and the rat line used may explain the discrepancies in the results found by the different research groups aforementioned. It is worth noting that the open-field behavioral assessments in our study were performed in the adult phase, whereas the AAS administration was performed beforehand in the animals' prepubertal phase.
Although the OFT is used to evaluate anxiety-related behavior through observation of animal exploration in the center and periphery of the apparatus, the study by Ramos [64] reported that multiple behavioral tests, including the EPM test, must be conducted for a better understanding of the mechanism of emotional behavior in rodents. Therefore, the EPM test is considered a quite useful and valid instrument to measure anxiety [29] .
Some animal models of anxiety evoke fear-motivated or defensive behaviors, analogous to anxious manifestations in individuals with anxiety disorders, by simply exposing the animal to a new environment or stimulus. The entries and time spent in the open and closed arms are considered a reliable index of anxiety. Thus, the higher levels of anxiety are, the lower percentage of open-arm entries and time spent in open arms will be, and vice versa. The number of closed-arm entries may also be positively correlated with the exploratory activity of animals [65] .
Very little is known about the effects of AAS on anxiety. The first study of these effects of AAS was performed by Bitran et al. [56] , who showed that high doses of TP alter the behavior of Long-Evans rats in the EPM apparatus. In this study, the animals were tested after 6 and 14 days of treatment with TP. The animals increased their exploration into the open arms after 6 days of treatment; that is, they showed an anxiolytic effect. However, animals treated with TP were not different from the control group after 14 days of treatment. These results indicate the transient anxiolytic character of the TP treatment. The few studies that have addressed AAS and anxiety generally showed controversial results [66, 67] .
In the present study, there was a statistically significant difference in the number of entries into the closed arms and time spent in the open arms between the groups in the EPM. Therefore, the changes observed in the animals from the group treated with the AAS, specifically increased exploratory behavior and anxiety-related behavior (anxiogenic effect), are contrary to those observed in another study that noted an anxiolytic effect induced by AAS [66] . Conversely, our results are similar to those observed in the study by Kouvelas et al. [68] . In this study, the authors treated male Wistar rats with ND at a dose of 15 mg/kg (s.c.) for 6 weeks daily. The study by Bing et al. [55] also showed an anxiolytic effect in Wistar rats, albeit caused by a single injection of testosterone (5 mg/kg), tested in the VOGEL'S test, 24 h after administering the drug. The evaluation time in the maze used in the present study (8 weeks after initiation of the treatment with the AAS) may not have been adequate to evaluate a possible transient anxiolytic effect of the AAS because TP promotes a short-term anxiolytic effect, as previously described [66] . In any case, although the administration of the AAS was performed in the prepubertal phase, the anxiogenic effect was most interestingly observed in the adult phase despite the discontinuation of treatment. Although neurochemical studies must be performed in this model, it may be speculated that testosterone injected in a temporal window important for the maturation of neural circuitry involved in the regulation of specific types of behavior may have irreversibly changed these animals' behavior in the adult phase.
Most organs receive sympathetic and parasympathetic innervations, which often mediate opposing actions [69] . The autonomic nervous system (ANS) affects the cardiovascular system tonically and reflexively, and modifies cardiac output by changing the strength of contraction of myocardial fibers and heart rate. In the vessels, the ANS modifies vascular smooth muscle contractility and, thus, peripheral vascular resistance [70] . Therefore, the ANS is a key mechanism of blood pressure control. Alterations in this system may lead to dysautonomia, which may adversely affect health. This change causes effects ranging from occasional episodes of neurally mediated hypotension to progressive neurodegenerative diseases. The increase in cardiac and renal sympathetic tone causes the development of essential hypertension, and cardiac sympathetic activation in chronic heart failure impairs myocardial function. Several other disorders are related to autonomic dysfunction, including type II diabetes, chronic fatigue syndrome, visceral obesity, dyslipidemia and Parkinson's disease, among others [69] .
Studies of the direct effects of AAS administration on ANS activity are scarce in the literature thus far. A study related stanozolol (a highly potent anabolic androgenic steroid) with an increase in blood pressure and a change in baroreflex activity, with no change in sympathetic activity in animals treated with the drug [71] . Proposed mechanisms for modifying cardiovascular reflex control include the synthesis of nitric oxide (NO) and the central control of the vagus nerve, namely increased glutamatergic activity in the hypothalamus and hippocampus [71] . However, in a study from our group using ND, we observed reduced vagal modulation and a tendency towards increased sympathetic modulation after its administration [22] . Lastly, an experimental study induced ischemia and ventricular fibrillation in rats using doses ranging from 40 to 160 mg/kg/min nandrolone by unclear mechanisms [72] . Therefore, further research studies on this subject are needed [39] .
Several studies have previously shown increased activity of the sympathetic nervous system (SNS) in models of anxiety, for example: Shaji and Kulkarni [73] and Inagaki et al. [74] . Furthermore, the results from the hydroelectrolytic study showed an increase in water intake and, although not evaluated, a possible retention of sodium in animals treated with AAS. We sought to examine autonomic modulation (sympathetic-vagal balance) in all animals because the SNS has a key effect in the latter process.
The assessment of HRV performed in both the time and frequency domains suggested that AAS treatment increased sympathetic modulation and decreased parasympathetic modulation; thus, SDNN (ms) and RMSSD (ms) significantly decreased upon AAS treatment, which corroborates the decreased parasympathetic modulation reported by Aubert et al. [32] . In the spectral analysis, the predominance of sympathetic modulation in the frequency domain was also observed in the testosterone-treated group, which was suggested by the increase in the ratio between the low-(LF) and high-frequency (HF) wave powers (LF/HF). Pereira et al. [22] showed that supraphysiological AAS administration, specifically of ND, altered cardiac autonomic control, damaging parasympathetic control in rats. The authors also speculate that such AAS-induced changes in cardiac autonomic control may trigger arrhythmias or sudden death before significant cardiovascular changes become evident.
The hydroelectrolytic homeostasis and its physiological consequences have been the focus of many studies. Water intake has often been regarded as one of many regulatory mechanisms of body volume and osmolality [75] . Several vasoactive peptides, in particular angiotensin II (ANG II), that circulate in plasma and are produced in various tissues, including the brain [76] , also act in the central nervous system (CNS) by changing the water intake [77] . There are several central peptidergic pathways capable of modulating water intake that may play a role in blood pressure (BP) and osmotic regulation. These various peptidergic systems may modulate water intake through changes in baroreceptor function and regulation of extracellular fluid osmolarity [78] .
In the present study, we showed that TP treatment during the prepubertal phase (P26) of rats sufficed to alter the basal intake of fluids towards decreasing the intake/preference for sodium in the adult phase (P90). In contrast to the sodium depletion paradigm, the animals in the AAS group appear to have developed an exaggerated aversion to 1.8% NaCl at baseline conditions in the adult phase. A study conducted by Rouah-Rosilio et al. [79] considers the existence of two morphological and physiological substrates of the serotonergic system, which integrates spontaneous and induced regulation of sodium intake. The experiments performed by Yamada et al. [80] showed that neural circuits that integrate the subfornical organ (SFO) and Raphe regions (dorsal raphe nucleus (DRN) especially) would evoke responses intrinsic to the regulation of body fluids. Additionally, testosterone induces an increase in the firing rate of serotonergic neurons by extracellular recording in rats [81] . This observation is based on, at least partially, the evidence obtained in the present work, whereas several reports in the literature have shown that increased serotoninergic activity from the DRN causes satiety for 1.8% NaCl, particularly in rats previously subjected to the paradigm of the free choice between distilled water and hypertonic saline [37, 82] . However, the significant reduction in the preference for sodium should not be attributed solely to this midbrain inhibitory mechanism. Therefore, sodium retention in this condition could contribute to an aversion for sodium during chronic treatment with testosterone. In this context, the direct upregulation of α-ENaC mRNA expression by testosterone via the androgen receptor has been demonstrated in vitro (human renal cell line HKC-8) and in vivo (rat model) studies [83] .
There is no data in literature concerning effects of prepubertally androgen treatment in hydroelectrolytic balance of adult rats. It has already been described that androgen treatment increased the expression/activity of peripheral renin-angiotensin system, e.g., upregulated angiotensinogen gene expression, renin activity and AT1R expression of adult rats [84] [85] [86] [87] . Notwithstanding, there are evidences that intramuscular injection of testosterone decreases water intake in a model of polyethylene glycol-induced hypovolemia in ovariectomized but not in orquiectomized adult rats [33] . It remains unclear the possible influence of androgens on the brain angiotensinergic system and correlated water and salt intake in different experimental paradigms, as like this used herein.
In the present study, we found no statistically significant differences in relative liver weight between experimental groups. Some authors report a correlation between the development of benign and malignant tumors in the liver with the use of AAS in the literature [88] [89] [90] [91] , which could cause an increased weight. Perhaps such changes in relative liver weight could occur over a longer treatment period. Studies conducted by Sánchez-Osorio et al. [92] showed consistent results of increased liver mass and increase of liver collagen deposition after prolonged use of AAS. Liver structure and function may also be altered by the administration of anabolic steroids, causing conditions including: cholestatic jaundice; peliosis hepatis; hepatocellular hyperplasia and hepatocellular adenoma [93, 94] ; and increased liver enzymes, including aspartate aminotransferase, which may be observed in hepatic necrosis; and increased risk for tumors in accordance with the time of exposure to the drug [94] .
We also found no statistically significant differences in relative heart weight between groups. Urhausen et al. [95] related the use of anabolic steroids with changes in the cardiac muscle characterized by left ventricular hypertrophy in a study with human subjects. Liu et al. [96] also reported hypertrophy in rats and humans. Furthermore, studies published in the literature have related AAS abuse by young male athletes to various adverse cardiovascular effects [97] [98] [99] [100] . The protocol used for AAS administration in our study was most likely insufficient to induce significant alterations (heart weight/cardiac hypertrophy) in our model. However, it is worth noting that the same protocol sufficed to alter the cardiac sympathetic-vagal balance towards increased sympathetic modulation, a key generator of cardiac arrhythmias [101] . Thus, from the translational standpoint, this study gains importance because sudden death in AAS users who show no significant cardiovascular alterations relevant in routine examinations is not a rare occurrence [102] .
We found no statistically significant differences in relative lung weight between the study groups. This data also supports the hypothesis that the protocol of AAS administration in this study failed to significantly affect the cardiovascular hemodynamics to the point of inducing congestive heart failure or severe pulmonary arterial hypertension. However, our protocol was capable of inducing subtle hydroelectrolytic and autonomic alterations that may help to explain the occurrence of sudden deaths in apparently healthy AAS users (athletes or not), even when the abuse occurred only in the adolescence phase. Hemodynamic studies in our model will be essential to strengthen this hypothesis.
In general, the results from this study enable us to conclude that AAS treatment during a critical life period (adolescence) may cause irreversible behavioral, autonomic and hydroelectrolytic changes that may be observed in the adult phase even when the AAS treatment is discontinued at the beginning of the adult phase.
